Class information for:
Level 1: SYSTEMIC SCLEROSIS//SCLERODERMA//SCLERODERMA RENAL CRISIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2316 2217 32.6 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1184 8906 SYSTEMIC SCLEROSIS//SCLERODERMA//RAYNAUDS PHENOMENON

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SYSTEMIC SCLEROSIS Author keyword 201 24% 33% 726
2 SCLERODERMA Author keyword 118 24% 20% 436
3 SCLERODERMA RENAL CRISIS Author keyword 60 72% 2% 48
4 ANTICENTROMERE ANTIBODIES Author keyword 23 59% 1% 26
5 ANTITOPOISOMERASE I ANTIBODIES Author keyword 18 89% 0% 8
6 RENAL CRISIS Author keyword 16 58% 1% 18
7 SCLERODERMA PROGRAM Address 15 42% 1% 28
8 ANTI TOPOISOMERASE I ANTIBODIES Author keyword 14 100% 0% 7
9 ANTI RNA POLYMERASE III Author keyword 12 86% 0% 6
10 MODIFIED RODNAN SKIN SCORE Author keyword 11 69% 0% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SYSTEMIC SCLEROSIS 201 24% 33% 726 Search SYSTEMIC+SCLEROSIS Search SYSTEMIC+SCLEROSIS
2 SCLERODERMA 118 24% 20% 436 Search SCLERODERMA Search SCLERODERMA
3 SCLERODERMA RENAL CRISIS 60 72% 2% 48 Search SCLERODERMA+RENAL+CRISIS Search SCLERODERMA+RENAL+CRISIS
4 ANTICENTROMERE ANTIBODIES 23 59% 1% 26 Search ANTICENTROMERE+ANTIBODIES Search ANTICENTROMERE+ANTIBODIES
5 ANTITOPOISOMERASE I ANTIBODIES 18 89% 0% 8 Search ANTITOPOISOMERASE+I+ANTIBODIES Search ANTITOPOISOMERASE+I+ANTIBODIES
6 RENAL CRISIS 16 58% 1% 18 Search RENAL+CRISIS Search RENAL+CRISIS
7 ANTI TOPOISOMERASE I ANTIBODIES 14 100% 0% 7 Search ANTI+TOPOISOMERASE+I+ANTIBODIES Search ANTI+TOPOISOMERASE+I+ANTIBODIES
8 ANTI RNA POLYMERASE III 12 86% 0% 6 Search ANTI+RNA+POLYMERASE+III Search ANTI+RNA+POLYMERASE+III
9 MODIFIED RODNAN SKIN SCORE 11 69% 0% 9 Search MODIFIED+RODNAN+SKIN+SCORE Search MODIFIED+RODNAN+SKIN+SCORE
10 ANTI TOPOISOMERASE I 11 78% 0% 7 Search ANTI+TOPOISOMERASE+I Search ANTI+TOPOISOMERASE+I

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SCLERODERMA 128 17% 31% 695
2 SERUM ANTINUCLEAR ANTIBODIES 61 77% 2% 41
3 ANTICENTROMERE ANTIBODIES 49 46% 4% 79
4 ANTI SCL 70 ANTIBODIES 45 94% 1% 16
5 PROGRESSIVE SYSTEMIC SCLEROSIS 45 25% 7% 159
6 HLA DQB1 1ST DOMAIN 40 71% 1% 32
7 LOW DOSE PENICILLAMINE 38 93% 1% 14
8 SCLERODERMA RENAL CRISIS 36 52% 2% 49
9 SKIN THICKNESS SCORE 33 62% 2% 34
10 ORAL AZATHIOPRINE 31 92% 1% 12

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Scleroderma renal crisis 2015 2 50 88%
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 2015 3 37 59%
Diagnosis and Classification of Systemic Sclerosis 2011 40 13 100%
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-Results from the International Scleroderma Renal Crisis Survey 2014 6 10 100%
Autoantibodies in systemic sclerosis 2005 217 46 70%
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies 2012 40 43 65%
Incidence and prevalence of systemic sclerosis: A systematic literature review 2008 105 34 76%
Mortality in systemic sclerosis: an international meta-analysis of individual patient data 2005 179 29 69%
Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers 2012 28 30 80%
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature 2014 12 29 41%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SCLERODERMA PROGRAM 15 42% 1.3% 28
2 SCLERODERMA CLIN 4 67% 0.2% 4
3 CLIN IMMUNOL ALLERGOL UNIT 4 75% 0.1% 3
4 AMURR 3 100% 0.1% 3
5 REFERENCE SCLERODERMIE SYST 3 40% 0.3% 6
6 ROGER WILLIAMS GEN HOSP 3 45% 0.2% 5
7 GRP PNEUMOL 2 44% 0.2% 4
8 DENOTHE CAREGGI HOSP AOUC 2 67% 0.1% 2
9 GRP RECH EPITHELIUM P INFLAMMAT 2 67% 0.1% 2
10 SCLERODERMA SARCOIDOSIS PATIENT CARE 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000261838 SYSTEMIC SCLEROSIS//SCLERODERMA//TIGHT SKIN MOUSE
2 0.0000258120 SCLERODERMA HEART DISEASE//HEART INVOLVEMENT//SMALL CORONARY ARTERY DISEASE
3 0.0000177804 RAYNAUDS PHENOMENON//CAPILLAROSCOPY//DIGITAL ULCERS
4 0.0000172466 UCLA SCTC GIT 20//ESOPHAGEAL TRANSIT STUDY//OESOPHAGEAL SCINTIGRAPHY
5 0.0000106911 PARRY ROMBERG SYNDROME//LOCALIZED SCLERODERMA//MORPHEA
6 0.0000098127 ANTINUCLEAR ANTIBODIES//INDIRECT IMMUNOFLUORESCENCE//ANA
7 0.0000079574 MIXED CONNECTIVE TISSUE DISEASE//LA SS B//RO SS A
8 0.0000075485 PULMONARY RHEUMATOID NODULE//RHEUMATOID LUNG//RHEUMATOID PLEURITIS
9 0.0000068068 KL 6//KREBS VON DEN LUNGEN 6//BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUG
10 0.0000059107 PULMONARY ARTERIAL HYPERTENSION//TREPROSTINIL//PULMONARY HYPERTENSION